Walleye Trading
MYGN icon

Walleye Trading’s Myriad Genetics MYGN Stock Holding History

Walleye Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46,200
Closed -$1.27M – 5698
2021
Q4 		$1.27M Sell
46,200
-42,800
-48% -$1.24M ﹤0.01% 2023
2021
Q3 		$2.87M Buy
+89,000
New +$2.96M 0.01% 1308
2021
Q1 		– Sell
-27,700
Closed -$548K – 5120
2020
Q4 		$548K Sell
27,700
-4,300
-13% -$69.4K ﹤0.01% 2579
2020
Q3 		$417K Buy
32,000
+2,700
+9% +$34.2K ﹤0.01% 2394
2020
Q2 		$332K Buy
29,300
+10,400
+55% +$148K ﹤0.01% 2621
2020
Q1 		$270K Sell
18,900
-6,600
-26% -$139K ﹤0.01% 2372
2019
Q4 		$694K Sell
25,500
-7,700
-23% -$212K ﹤0.01% 2120
2019
Q3 		$951K Buy
33,200
+17,600
+113% +$513K 0.01% 1643
2019
Q2 		$433K Buy
15,600
+6,600
+73% +$186K ﹤0.01% 2307
2019
Q1 		$299K Sell
9,000
-28,800
-76% -$877K ﹤0.01% 2705
2018
Q4 		$1.1M Sell
37,800
-4,400
-10% -$158K 0.01% 1613
2018
Q3 		$1.94M Buy
42,200
+19,900
+89% +$885K 0.01% 1373
2018
Q2 		$833K Buy
22,300
+14,600
+190% +$493K ﹤0.01% 2295
2018
Q1 		$228K Sell
7,700
-3,100
-29% -$105K ﹤0.01% 3389
2017
Q4 		$371 Buy
10,800
+2,100
+24% +$70.8K ﹤0.01% 2901
2017
Q3 		$316 Sell
8,700
-27,800
-76% -$793K ﹤0.01% 2874
2017
Q2 		$944 Buy
36,500
+15,500
+74% +$329K 0.01% 1827
2017
Q1 		$405 Buy
+21,000
New +$372K ﹤0.01% 2424
2016
Q4 		– Sell
-200
Closed -$4K – 5011
2016
Q3 		$4K Sell
200
-2,700
-93% -$68.5K ﹤0.01% 4594
2016
Q2 		$88K Buy
2,900
+1,900
+190% +$66K ﹤0.01% 3606
2016
Q1 		$38K Buy
1,000
+900
+900% +$33.9K ﹤0.01% 4065
2015
Q4 		$4K Sell
100
-10,000
-99% -$422K ﹤0.01% 4976
2015
Q3 		$378K Buy
+10,100
New +$358K ﹤0.01% 1782
2014
Q2 		– Sell
-400
Closed -$13 – 3936
2014
Q1 		$13 Buy
+400
New +$12.4K ﹤0.01% 3169

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Walleye Trading's MYGN Position: Q3 2022 in Review

Walleye Trading sold out of Myriad Genetics (MYGN) in Q3 2022, closing a stake of 12,446 shares — an estimated $226K sold.

Walleye Trading first reported a position in MYGN in Q2 2013 and held it in 17 quarters. The position peaked at $1.36M in Q3 2015. 191 funds tracked by Wall St. Rank hold MYGN as of Q3 2022.

  • Walleye Trading reported no remaining Myriad Genetics position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 12,446 Myriad Genetics shares in Q3 2022, an estimated $226K.
  • Walleye Trading first reported a position in Myriad Genetics in Q2 2013 and held it in 17 quarters.
  • Walleye Trading's Myriad Genetics position peaked at $1.36M in Q3 2015.
  • 191 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.